Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh.
Journal
The New England journal of medicine
ISSN: 1533-4406
Titre abrégé: N Engl J Med
Pays: United States
ID NLM: 0255562
Informations de publication
Date de publication:
09 05 2019
09 05 2019
Historique:
entrez:
9
5
2019
pubmed:
9
5
2019
medline:
22
5
2019
Statut:
ppublish
Résumé
Nipah virus is a highly virulent zoonotic pathogen that can be transmitted between humans. Understanding the dynamics of person-to-person transmission is key to designing effective interventions. We used data from all Nipah virus cases identified during outbreak investigations in Bangladesh from April 2001 through April 2014 to investigate case-patient characteristics associated with onward transmission and factors associated with the risk of infection among patient contacts. Of 248 Nipah virus cases identified, 82 were caused by person-to-person transmission, corresponding to a reproduction number (i.e., the average number of secondary cases per case patient) of 0.33 (95% confidence interval [CI], 0.19 to 0.59). The predicted reproduction number increased with the case patient's age and was highest among patients 45 years of age or older who had difficulty breathing (1.1; 95% CI, 0.4 to 3.2). Case patients who did not have difficulty breathing infected 0.05 times as many contacts (95% CI, 0.01 to 0.3) as other case patients did. Serologic testing of 1863 asymptomatic contacts revealed no infections. Spouses of case patients were more often infected (8 of 56 [14%]) than other close family members (7 of 547 [1.3%]) or other contacts (18 of 1996 [0.9%]). The risk of infection increased with increased duration of exposure of the contacts (adjusted odds ratio for exposure of >48 hours vs. ≤1 hour, 13; 95% CI, 2.6 to 62) and with exposure to body fluids (adjusted odds ratio, 4.3; 95% CI, 1.6 to 11). Increasing age and respiratory symptoms were indicators of infectivity of Nipah virus. Interventions to control person-to-person transmission should aim to reduce exposure to body fluids. (Funded by the National Institutes of Health and others.).
Sections du résumé
BACKGROUND
Nipah virus is a highly virulent zoonotic pathogen that can be transmitted between humans. Understanding the dynamics of person-to-person transmission is key to designing effective interventions.
METHODS
We used data from all Nipah virus cases identified during outbreak investigations in Bangladesh from April 2001 through April 2014 to investigate case-patient characteristics associated with onward transmission and factors associated with the risk of infection among patient contacts.
RESULTS
Of 248 Nipah virus cases identified, 82 were caused by person-to-person transmission, corresponding to a reproduction number (i.e., the average number of secondary cases per case patient) of 0.33 (95% confidence interval [CI], 0.19 to 0.59). The predicted reproduction number increased with the case patient's age and was highest among patients 45 years of age or older who had difficulty breathing (1.1; 95% CI, 0.4 to 3.2). Case patients who did not have difficulty breathing infected 0.05 times as many contacts (95% CI, 0.01 to 0.3) as other case patients did. Serologic testing of 1863 asymptomatic contacts revealed no infections. Spouses of case patients were more often infected (8 of 56 [14%]) than other close family members (7 of 547 [1.3%]) or other contacts (18 of 1996 [0.9%]). The risk of infection increased with increased duration of exposure of the contacts (adjusted odds ratio for exposure of >48 hours vs. ≤1 hour, 13; 95% CI, 2.6 to 62) and with exposure to body fluids (adjusted odds ratio, 4.3; 95% CI, 1.6 to 11).
CONCLUSIONS
Increasing age and respiratory symptoms were indicators of infectivity of Nipah virus. Interventions to control person-to-person transmission should aim to reduce exposure to body fluids. (Funded by the National Institutes of Health and others.).
Identifiants
pubmed: 31067370
doi: 10.1056/NEJMoa1805376
pmc: PMC6547369
mid: NIHMS1529615
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
1804-1814Subventions
Organisme : FIC NIH HHS
ID : R01 TW005869
Pays : United States
Organisme : NIH HHS
ID : 2R01-TW005869
Pays : United States
Organisme : Seventh Framework Programme
ID : 278433
Pays : International
Informations de copyright
Copyright © 2019 Massachusetts Medical Society.
Références
N Engl J Med. 2000 Apr 27;342(17):1229-35
pubmed: 10781618
J Infect. 2001 Jan;42(1):40-3
pubmed: 11243752
Microbes Infect. 2001 Apr;3(4):289-95
pubmed: 11334746
Soc Sci Med. 2004 Nov;59(10):2025-36
pubmed: 15351470
Emerg Infect Dis. 2004 Dec;10(12):2082-7
pubmed: 15663842
Nature. 2005 Nov 17;438(7066):355-9
pubmed: 16292310
Emerg Infect Dis. 2005 Oct;11(10):1594-7
pubmed: 16318702
Emerg Infect Dis. 2006 Feb;12(2):235-40
pubmed: 16494748
Soc Sci Med. 2007 Mar;64(6):1166-77
pubmed: 16890336
Emerg Infect Dis. 2007 Jul;13(7):1031-7
pubmed: 18214175
Clin Infect Dis. 2008 Apr 1;46(7):977-84
pubmed: 18444812
Emerg Infect Dis. 2008 Oct;14(10):1526-32
pubmed: 18826814
Emerg Infect Dis. 2009 Aug;15(8):1229-35
pubmed: 19751584
Epidemiol Infect. 2010 Nov;138(11):1630-6
pubmed: 20380769
PLoS One. 2010 Oct 21;5(10):e13570
pubmed: 21042407
Emerg Infect Dis. 2011 May;17(5):907-9
pubmed: 21529409
Vector Borne Zoonotic Dis. 2012 Jan;12(1):65-72
pubmed: 21923274
Emerg Infect Dis. 2012 Feb;18(2):248-55
pubmed: 22304936
Emerg Infect Dis. 2013 Feb;19(2):210-7
pubmed: 23347678
Antiviral Res. 2013 Oct;100(1):38-43
pubmed: 23911335
Am J Infect Control. 2014 Mar;42(3):305-10
pubmed: 24406254
Epidemiol Infect. 2015 Jul;143(9):1922-30
pubmed: 25342551
Lancet Infect Dis. 2015 Mar;15(3):320-6
pubmed: 25619149
Emerg Infect Dis. 2015 Feb;21(2):349-51
pubmed: 25625615
Emerg Infect Dis. 2015 Feb;21(2):328-31
pubmed: 25626011
Epidemiol Infect. 2016 Jan;144(2):371-80
pubmed: 26122675
PLoS Med. 2015 Dec 01;12(12):e1001908
pubmed: 26625118
Emerg Infect Dis. 2016 Apr;22(4):664-70
pubmed: 26981928
Ecohealth. 2016 Dec;13(4):720-728
pubmed: 27738775
Emerg Infect Dis. 2018 Jan;24(1):15-21
pubmed: 29260663
Clin Microbiol Infect. 2018 Oct;24(10):1113-1114
pubmed: 29935330